Product Images Paclitaxel

This appears to be a table displaying the proportion surviving over four years. It includes columns labeled "Number at Risk" and "No. events" and includes percentages for "HRO5%C". Without further context, it is not possible to provide a more detailed description of the data.*

This text provides survival data analysis with the number of events, proportion surviving, hazard ratio (HR) with the 95% confidence interval for a certain population.*

The text is a table indicating the proportion of disease-free instances. It has two columns and multiple rows, with some numbers in the cells. The first column seems to indicate the types of data being analyzed, while the second column displays numbers and percentages. At the bottom, there is a row with the number at risk.*

This is a table showing the proportion of disease-free patients for two treatments called AC and AC+T. The number of people at risk for each treatment is also provided. There is a column called "No. events" which indicates the number of patients who experienced a disease-related event. An HR value of 0.2 is reported, but its meaning is unclear from this text.*

This is a medical report that shows the proportion of the population who are disease free over a period of 8 years. The report includes the number of events (201 and 173) and a hazard ratio (0.83). It also lists the number of people at risk in two treatment groups (AC+T and AC) over a period of 4 years.*

This appears to be a table. The title "PROPORTION DISEASE FREE" suggests that it may be displaying data related to disease survival rates or disease recurrence rates. The columns seem to represent different treatment options or groups (AC and AC+T), with the number of events (140 and 110) and number of patients at risk (562, 304, 514, and 289) shown over a three-year span. The HR (hazard ratio) of 0.73 with a 95% CI (confidence interval) of 0.57 to 0.93 may indicate a difference in disease-free survival rates between the two treatment groups.*

This is a description of a medication called Injection, USP containing 30mg of Paclitaxel USP per 5mL Multi-Dose Vial made in India. The usual dosage is not specified and it is recommended to store at 20-25°C. The medication carries the code AP/DRUGS/03/2011 and is manufactured for Athenex in Schaumburg, IL (USA). The medication also contains Polyoxyl 35 Castor Oil NF and must be handled with gloves.*

This is a description of a drug called Paclitaxel, which is a cytotoxic agent. It is sterile, non-pyrogenic and preservative-free. The container closure is not made with natural rubber latex. Each mL of the drug contains 6 mg of Paclitaxel USP, 527 mg of Polyoryl 35 Castor OF NF, 49.7% (VIV) Dehydrated Alcohol, USP, and 2 mg Cltric Acd, USP. The drug requires dilution before intravenous infusion. There are three variants of the drug, namely- a multi-dose vial, a single-dose vial, and injection, USP. The doses and precautions for the drug should be followed as directed in the insert. The drug should be stored at 20°C to 25°C (68°F to 77°F) in the carton and protected from light. At all times when handling containers, gloves should be worn. The drug is manufactured by Athenex in India.*

This text contains information about a drug called Paclitaxel, which is an injection used in chemotherapy and a cytotoxic agent. The drug is made in India for the company Athenex in Schaumburg, USA and was copyrighted in 2016. The text also includes a unique code number, manufacturing details, and cautionary notes regarding dilution before intravenous infusion. NDC or National Drug Code number is also mentioned as 70860-200-17 with strengths of 100 mg per 16 (6 mg per mL).*

EachmL of the solution contains 6mg of Paclitaxel USP, 527 mg of Polyoxyl 35 Castor Oil NF, 49.7% (VV) Dehydrated Alcohol, USP and 2 mg of Citric Acid USP. It is a cytotoxic agent with a usual dosage mentioned in the insert. The injection is available in a pack of 1x16.7mL and should be stored at 20° to 25°C. It must be protected from light and retained in the carton until the time of use. Dilution is necessary before Intravenous Infusion, and gloves should be worn during handling containers.*

This is a description of a medication called Paclitaxel Injection, which is a cytotoxic agent used to treat cancer. The medication comes in a sterile, non-pyrogenic, mult-dose vial with 300mg per 50mL (6mg per mL) of the active ingredient. The container closure is not made with natural rubber latex. It also contains Palyoxyl 35 Castor O NF, Dehydrated Alcohol USP, and Citric Acid USP. The dosage, directions for use, and precautions can be found in the enclosed insert. The medication should be stored at 20-25°C and protected from light until time of use. Dilution is required prior to intravenous infusion. Gloves should be worn when handling. This medication is manufactured by Abenex and the code is APDRUGSARZ01.*